EAE TEACHING COURSE Aorta and aortic valve 2012



Similar documents
Low-gradient severe aortic stenosis with normal LVEF: A disturbing clinical entity

Aortic Valve Stenosis and CAD

Management of the Patient with Aortic Stenosis undergoing Non-cardiac Surgery

Managing Mitral Regurgitation: Repair, Replace, or Clip? Michael Howe, MD Traverse Heart & Vascular

Mitral Valve Repair versus Replacement for Severe Ischemic Mitral Regurgitation. Michael Acker, MD For the CTSN Investigators AHA November 2013

Stress-echocardiography to guide decision making in valvular heart disease: Low-Flow, Low-Gradient Aortic Stenosis

Provider Checklist-Outpatient Imaging. Checklist: Nuclear Stress Test, Thallium/Technetium/Sestamibi (CPT Code )

Section 8: Clinical Exercise Testing. a maximal GXT?

Dysfunction of aortic valve prostheses

5. Management of rheumatic heart disease

Aortic Stenosis and Comorbidities: the clinical challenge. P. Faggiano Cardiology Division Spedali Civili, Brescia - Italy

Fellow TEE Review Workshop Hemodynamic Calculations Director, Intraoperative TEE Program. Johns Hopkins School of Medicine

Cardiac Assessment for Renal Transplantation: Pre-Operative Clearance is Only the Tip of the Iceberg

Treating AF: The Newest Recommendations. CardioCase presentation. Ethel s Case. Wayne Warnica, MD, FACC, FACP, FRCPC

2/20/2015. Cardiac Evaluation of Potential Solid Organ Transplant Recipients. Issues Specific to Transplantation. Kidney Transplantation.

2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary

CARDIAC RISKS OF NON CARDIAC SURGERY

ATRIAL FIBRILLATION (RATE VS RHYTHM CONTROL)

How To Treat Aortic Stenosis

123 Main St NY, New York ph: (202) fax: (202)

38 year old female with mild obesity. She is planning an exercise program to loose weight. She has no other known risk factors for CAD.

Cardiovascular Guidelines for DOT Physical Exams By Maureen Collins MSN, APRN, BC

Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice

Type II Pulmonary Hypertension: Pulmonary Hypertension due to Left Heart Disease

Guidelines on the management of valvular heart disease

Clinical Commissioning Policy Statement: Percutaneous mitral valve leaflet repair for mitral regurgitation April Reference: NHSCB/A09/PS/b

TAVR: A New Treatment Option for Aortic Stenosis. Alexis Auger, MSN, NP-BC

INTRODUCTION TO EECP THERAPY

Non Invasive Testing for CAD

Effect of Spinal Cord Stimulation on Myocardial Flow Reserve in Patients with Refractory Angina Pectoris

AORTIC STENOSIS. Marie-Jeanne Bertrand MD MSc

Listen to your heart: Good Cardiovascular Health for Life

Steven J. Yakubov, MD FACC For the CoreValve US Clinical Investigators

Echocardiographic Assessment of Valve Stenosis: EAE/ASE Recommendations for Clinical Practice

Medical management of CHF: A New Class of Medication. Al Timothy, M.D. Cardiovascular Institute of the South

In-Hospital Results in 4,571 TAVI Patients

Cardiogenic Shock + Critical Aortic Stenosis = Run the Other Way?!!!

Transcatheter Mitral Valve-in-Valve and Valve-in-Ring Implantations. Danny Dvir, MD On behalf of VIVID registry investigators

on behalf of the AUGMENT-HF Investigators

RACE I Rapid Assessment by Cardiac Echo. Intensive Care Training Program Radboud University Medical Centre NIjmegen

Main Effect of Screening for Coronary Artery Disease Using CT

doi: /j.jacc This information is current as of March 16, 2011

NAME OF THE HOSPITAL: 1. Coronary Balloon Angioplasty: M7F1.1/ Angioplasty with Stent(PTCA with Stent): M7F1.3

Ultrasound in Vascular Surgery. Torbjørn Dahl

Non-Invasive Risk Predictors in (Children with) Pulmonary Hypertension

Perioperative Risk Stratification for Noncardiac Surgical Patients with Cardiac Diagnosis. Michael A. Blazing

May 1 6, 2016 Loews Atlanta Hotel Atlanta, GA PRELIMINARY PROGRAM AT A GLANCE

Inpatient Heart Failure Management: Risks & Benefits

Ruchika D. Husa, MD, MS Assistant t Professor of Medicine in the Division of Cardiology The Ohio State University Wexner Medical Center

Palpitations & AF. Richard Grocott Mason Consultant Cardiologist THH NHS Foundation Trust & Royal Brompton & Harefield NHS Foundation Trust

Perioperative Cardiac Evaluation

Guidelines: Congenital Aortic Valve Stenosis

RISK STRATIFICATION for Acute Coronary Syndrome in the Emergency Department

Riociguat Clinical Trial Program

Management of Atrial Fibrillation in Heart Failure

INHERIT. The Lancet Diabetes & Endocrinology In press

Elevated heart rate at twelve months after heart transplantation is an independent predictor of long term mortality

Mitral valve repair current Status and the modern Sternotomy

Cost-effectiveness analysis of TAVI compared to standard treatment of symptomatic aortic stenosis in patients at high surgical risk.

GERIATRYCZNE PROBLEMY KLINICZNE/GERIATRICS MEDICAL PROBLEMS

Objectives. Preoperative Cardiac Risk Stratification for Noncardiac Surgery. History

Vs. K. Farsalinos, D. Tsiapras, S. Kyrzopoulos, M. Savvopoulou, E. Avramidou, D. Vassilopoulou, V. Voudris

Atrial Fibrillation Based on ESC Guidelines. Moshe Swissa MD Kaplan Medical Center

What Do You Mean by Aortic Valve Area: Geometric Orifice Area, Effective Orifice Area, or Gorlin Area? Damien Garcia, Lyes Kadem

Treatment of Cardiac Device Infections

RATE VERSUS RHYTHM CONTROL OF ATRIAL FIBRILLATION: SPECIAL CONSIDERATION IN ELDERLY. Charles Jazra

Predictive Implications of Stress Testing (Chapt. 14) 1979, Weiner and coworkers. Factors to improve the accuracy of stress testing

Aortic Valve Surgery and Reduced Ventricular Function

James F. Kravec, M.D., F.A.C.P

Heart valve repair and replacement

Efficient Evaluation of Chest Pain

Quiz 5 Heart Failure scores (n=163)

Non-Invasive Positive Pressure Ventilation in Heart Failure Patients: For Who, Wy & When?

Results of the RHEUMATIC (Rheumatic Heart Echo Utilization and Monitoring Actuarial Trends in Indian Children) Study

Normal & Abnormal Intracardiac. Lancashire & South Cumbria Cardiac Network

Pre-Operative Cardiac Evaluation Kalpana Jain, MD

Diagnostic and Therapeutic Procedures

The debate: Should all AF patients see an EP consultant?

4/7/2015. Cardiac Rehabilitation: From the other side of the glass door. Chicago, circa Objectives. No disclosures, no conflicts

Name: Age: Resting BP: Wt. kg: Est. HR max : 85%HR max : Resting HR:

The Role Of Early Stress Testing In Assessing Low Risk Chest Pain Patients Admitted Through The Emergency Department

SECTION III: HEMODYNAMIC PRINCIPLES

The P Wave: Indicator of Atrial Enlargement

Richtlijn voor de chirurgische behandeling van hartklep-aandoeningen

Atrial Fibrillation The Basics

Systolic Blood Pressure Intervention Trial (SPRINT) Principal Results

Inconsistencies in the Use of Cardiac Biomarkers or Echocardiography in Patients with Acute Non-Massive Pulmonary Embolism

National Imaging Associates, Inc. Clinical guidelines

Geriatric Cardiology: Challenges and Strategies

Stent for Life Initiative How can we improve system delay and patients delay in STEMI

Septic Shock: Pharmacologic Agents for Hemodynamic Support. Nathan E Cope, PharmD PGY2 Critical Care Pharmacy Resident

The Sepsis Puzzle: Identification, Monitoring and Early Goal Directed Therapy

CTA OF THE EXTRACORONARY HEART

Electrocardiography Review and the Normal EKG Response to Exercise

JNC-8 Blood Pressure and ACC/AHA Cholesterol Guideline Updates. January 30, 2014

Anaesthesia and Heart Failure

Long term anticoagulant therapy in patients with atrial fibrillation at high risk of stroke: a new scenario after RE-LY trial

Pharmacologic Stress Agents: Protocol and Safety

2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease

Aortic Stenosis Tier 2 Overview

Transcription:

EAE TEACHING COURSE Aorta and aortic valve 2012 31th March 2012 Szczecin, Poland EP

EAE TEACHING COURSE: aorta and aortic valve Szczecin, 31st March 2012 Prof. Luigi Badano, Italy Prof. Patrizio Lancellotti, Belgium Prof. Frank Flachskampf, Germany Prof. Gilbert Habib, France & Prof. Edyta Plonska-Gosciniak, Prof. Jarosław Kasprzak, Prof. Zbigniew Gąsior, prof. Tomasz Kukulski, prof. Anna Klisiewicz

STRESS ECHO IN AORTIC VALVE DISEASES EAE Teaching Course. Aorta and aortic valve 2012 Edyta Płońska- Gościniak Szczecin, Poland

EAE stress echo [Sicari, EJE 2008]

STRESS ECHO IN AORTIC VALVE DISEASES EAE Teaching Course. Aorta and aortic valve 2012

STRESS ECHO IN AORTIC VALVE DISEASES EAE Teaching Course. Aorta and aortic valve 2012 Stress echo in valvular diseases Evaluation of symptoms Exercise capacity Hemodynamic consequences of valve diseases

STRESS ECHO IN AORTIC VALVE DISEASES EAE Teaching Course. Aorta and aortic valve 2012 Stress echo in aortic stenosis (AS) Indications: Assessment of AS severity and risk stratification in AS/depressed LV/ low-flow/low-grad Dob 5-20ug/kg/min Assessment for functional class and risk stratification in asymptomatic severe AS Dob 5-40ug/kg/min, exercise

Stress ECHO Low-flow/low-gradient aortic stenosis role of stress echo

Guidelines of Valvular Heart Disease ECHO is the only published stress imaging technique in patients with low-flow/low-gradient aortic stenosis EF<40%, Mgrad<30-40 mmhg, AVA<1cm2

STRESS ECHO IN AORTIC VALVE DISEASES EAE Teaching Course. Aorta and aortic valve 2012 Stress echo in low flow/grad aortic stenosis To detect the presence of contractile reserve (increase SV>20%) To distinguish truly severe AS from pseudosevere AS (changes in aortic velocity, mean grad, valve area) ESC Guidelines on management of valvular heart disease, 2007

STRESS ECHO IN AORTIC VALVE DISEASES EAE Teaching Course. Aorta and aortic valve 2012 The protocol The protocol for dobutamine stress echo for evaluation low-flow/ low-grad AS: Low dose dob 2,5 or 5 ug/kg/min with an incremental increase in the infusion in every 3-5 min to a maksimum dose 10-20 ug/kg/min Test termination: HR more than 10-20bpm over baseline or 100bpm (low dob) Guidelines EAE/ASE, 2009

STRESS ECHO IN AORTIC VALVE DISEASES EAE Teaching Course. Aorta and aortic valve 2012 Doppler data - report Each stage or at least at baseline and peak dose: LVOT velocity (VTI) AS jet velocity, mean gradient LVOT diameter only in rest calculation of valve area SV, EF Guidelines EAE/ASE, 2009

SAFETY: ADVERSE EVENTS DURING DOB ECHO IN AS (no death) (Plonska, n=162 AS pts)

SAFETY: ADVERSE EVENTS AND TEST TERMINATION (Plonska, n=162 AS pts)

SAFETY: STRESS ECHO ADVERSE EVENTS in Low Flow/Gradient AS (PLONSKA, group I n=39, low flow/grad vs group II n=123, moderate AS)

AS: LV dysfunction (< SV/EF ) due to afterload or primary LV dysfunction limited valve opening AVA < 1 cm TVA gradient 2 High Low ( mean < 30-40 ) Symptoms AVR (surgery) Classification of severe of AS Moderate AS LV dysfunction Severe AS secondary LV dysfunction Severe AS LV dysfunction (CAD/alcohol) Jet velocity (m/s) >4 Mean grad (mmhg) >50 Valve area (cm2) <1 Valve area index <0.6 In case of LV dysfunction, severe AS may be present with a lower grad/velocity - Guidelines, 2007

AS: LV dysfunction (< SV/EF ) due to afterload or primary LV dysfunction limited valve opening AVA < 1 cm TVA gradient 2 High Low ( mean < 30-40 ) Symptoms AVR (surgery) Classification of severe of AS Moderate AS LV dysfunction Severe AS secondary LV dysfunction Severe AS LV dysfunction (CAD/alcohol) Jet velocity (m/s) >4 Mean grad (mmhg) >50 Valve area (cm2) <1 Valve area index <0.6 In case of LV dysfunction, severe AS may be present with a lower grad/velocity - Guidelines, 2007

AS with depressed LV, low flow / high gradient Patient F, 67yr, Symptoms Grad 80/48, AVA < 1 EF No need stres echo

STRESS ECHO IN AORTIC VALVE DISEASES EAE Teaching Course. Aorta and aortic valve 2012 Stress echo in aortic stenosis Left ventricular systolic dysfunction AS: low flow / high gradient AS (mean grad >40, AVA <1, EF<40%) Does not need stress echo ESC Guidelines on management of valvular heart disease, 2007

AS: LV dysfunction (< SV/EF ) due to afterload or primary LV dysfunction limited valve opening AVA < 1 cm TVA gradient 2 High Low ( mean < 30-40 ) Symptoms AVR (surgery) Classification of severe of AS Moderate AS LV dysfunction Severe AS secondary LV dysfunction Severe AS LV dysfunction (CAD/alcohol) Jet velocity (m/s) >4 Mean grad (mmhg) >50 Valve area (cm2) <1 Valve area index <0.6 In case of LV dysfunction, severe AS may be present with a lower grad/velocity - Guidelines, 2007

Dobutamine echo in low-grad/low flow AS and LV dysfunction provides: Assessment of real severity of AS and contractile reserve 5 20 ug/kg/min R+: >SV by 20% ( WMSI,EF) (4 segments=0,25 WMSI) AS severity: R+ and AVA <1 cm2 (D 0,2) DE Severe AS Moderate AS Undetectable AS SV, EF Pressure grad AVA

DEAS in low-flow/low-grad AS and LV dysfunction DobAS Preserved contractile reserve Lack of contractile reserve Severe AS AVA const grad Moderate AS AVA > 0.2cm2 grad Favorably to AVR/surgery High risk pts Operative risk: 5 7 % Operative risk: 22-30 %

Low-flow/low - grad AS and LV dysfunction Dobutamine stress echo determines: True severe AS Moderate AS Acceptable operative mortality Improved long-term survival Increase in EF Less surgical benefit DEAS is reasonable to evaluate pts with low-flow/low-grad AS and LV dysfunction Guidelines, 2007

DE in low-flow/low-grad. AS Rest Stress DE EF MGrad AVA Plonska, Lancellotti Rest 22 23 0,66 Stress 39 44 0,67

Dobutamine stress echo in low-grad AS (Monin)

RESULTS AS-STUDY PLONSKA (Dob) 163 pts LV DYSFUNCTION (-) 124 pts LV DYSFUNCTION (+) 39 pts Plonska, et al.

Dobutamine echo in low-flow/low-grad AS Plonska(dob) n=39/163 n=27 R+ Perioperative mortality 9% n=12 R Perioperative mortality 29%

Patient 1: at rest 66 year old man with HF symptoms (III NYHA), LV dysfunction and calcified aortic valve, but mean grad only 29 and valve area 0.7. Significant LV dilatation and systolic dysfunction are present, so low gradient may understimate AS severity. DE can be performed to evaluate contractile reserve and determine severity of AS

Patient 1 stress: with contractile reserve and severe AS DE EF MGrad AVA Rest 30 29 0,7 Stress 46 43 0,7

DEAS in low-flow/low-grad AS and LV dysfunction DobAS Patient 1 R(+)/ severe AS Patient 2 R(-) Severe AS AVA const grad Moderate AS AVA > 0.2cm2 grad Favorably to AVR/surgery High risk pts/tavi Operative risk: 5 7 % Operative risk: 22-30 %

STRESS ECHO IN AORTIC VALVE DISEASES EAE Teaching Course. Aorta and aortic valve 2012 Perioper. mortality R + 6%, R - 33% Increase in EF by 10% in 83% with CR in 65% without CR Quere et al. Circulation. 2006;113: 1738-44

STRESS ECHO IN AORTIC VALVE DISEASES EAE Teaching Course. Aorta and aortic valve 2012 The test abnormal response Symptoms (dyspnoe, syncope, near syncope, angina pectoris) Blood pressure fall (>20mmHg) Significant ventricular arrythmias, ECG- ST Guidelines EAE/ASE, 2009

ESC indications for AVR in AS/symptoms ( - ) V>4m/s i >0,3m/s/rok Asymptomatic severe AS, n = 126, V > 4m/s, endpoint: death/avr (Rosenhek) Asymptomatic, n = 123, end point: death/avr (Otto)

STRESS ECHO IN AORTIC VALVE DISEASES EAE Teaching Course. Aorta and aortic valve 2012 Aortic stenosis: asymptomatic K-M: pts with severe asymptomatic AS f-up 60 month (exercise echo). Amato (2001): prognosis (death or symptoms). Criteria (+) test: symptoms, ST/arrythmias, BP fall.

STRESS ECHO IN AORTIC VALVE DISEASES EAE Teaching Course. Aorta and aortic valve 2012 Aortic stenosis: asymptomatic KM: pts with severe asymptomatic AS. Difference in mean gradient rest- stres Lancellotti (2005): prognosis (death or symptoms). Criteria (+) test: symptoms, ST/arrythmias, BP fall, increase in mean grad > 18mmHg

STRESS ECHO IN AORTIC VALVE DISEASES EAE Teaching Course. Aorta and aortic valve 2012 Stress echo in asymptomatic AS To unmask symptoms (30-40% pts) For risk stratification Increase in mean grad > 18 mmhg, abnormal test and AVA <0,75cm2 predicts a worse prognosis in severe AS (Lancellotti); stress increase mean grad >20mmHg in pts with normal test (Pibarot) ESC Guidelines on management of valvular heart disease, 2007

SUMMARY: STRESS ECHO IN AORTIC VALVE DISEASES EAE Teaching Course. Aorta and aortic valve 2012 ESC indications for AVR Class I: severe AS Symptom CABG/Ao/valve Asymptomatic EF<50% + stress echo

STRESS ECHO IN AORTIC VALVE DISEASES EAE Teaching Course. Aorta and aortic valve 2012 SUMMARY ESC indications for asymptomatic severe AS Class I test (+): symptoms Class IIa test (+): BP fall Class IIb test (+): arrythmias

STRESS ECHO IN AORTIC VALVE DISEASES EAE Teaching Course. Aorta and aortic valve 2012 SUMMARY: stress echo in asymptomatic severe AS It is accepted for risk stratification and assessment of functional class in asymptomatic pts

Szczeci